Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fed Condition
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics and bioequivalence of
Lamotrigine formulations after administration of single doses to non-smoking, healthy males
and females under fed conditions